Author:
Karlowsky James A.,Lob Sibylle H.,Kazmierczak Krystyna M.,Young Katherine,Motyl Mary R.,Sahm Daniel F.
Funder
Merck Sharp & Dohme Corp.
Subject
Microbiology (medical),Immunology,Immunology and Allergy,Microbiology
Reference20 articles.
1. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa;Livermore;J Antimicrob Chemother,2013
2. In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa;Young;BMC Microbiol,2019
3. United States Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212819s000lbl.pdf [accessed 20 August 2019].
4. In vitro activity of imipenem-relebactam against clinical isolates of Gram-negative Bacilli isolated in hospital laboratories in the United States as part of the SMART 2016 Program;Karlowsky;Antimicrob Agents Chemother,2018
5. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI M100;CLSI,2018
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献